MorrisonG., GehabM.A., EarleyL.E.Chronic renal failure. In: The Kidney Physiology and Pathophysiology, edited by SeldinD.W., and GiebischG.. Raven Press, New York, 1985; pp. 1901–1943.
2.
Beretta-PiccoliC., WeidmannP., Du ChatelP., ReubiR.: Hypertension associated with early end stage kidney disease. Am. J.Med.1976; 61: 739–747.
GuytonA.C., ColemanT.G., YoungD.B., LohmeierT.E., DeClueJ.W.: Salt balance and long-term blood pressure control. Ann. Rev.Med.1980; 31: 15–27.
5.
PostonL., SewellR.B., WilkinsonS.P., RichardsonP.J., WilliamsR., ClarksonE.M., MacGregorG.A., De WardenerH.E.: Evidence for a circulating sodium transport inhibitor in essential hypertension. Br. Med.J.1881; 282(1): 847–849.
6.
KimK.E., OnestiG.L., SwartzC.D.: Hemodynamics of hypertension in uremia.Kidney Int.1975; 8: S155–S162.
7.
BrodJ., FenclV., UlrychM.: General and regional hemodynamics in hypertension in chronic renal disease. Clin.Nephrol.1975; 5: 175–182.
8.
FrohlicE.B., TaraziR.C., DustanH.P.: Re-examination of the hemodynamics of hypertension. Amer. J. Med.Sci.1969; 257: 9–23.
9.
LeenenF.H.H., GallaS.J., GeyskesG.G., MurdaughH.V.Jr., ShapiroA.P.: Effects of hemodialysis and saline loading on body fluid compartments, plasma renin activity, and blood pressure in patients on chronic hemodialysis.Nephron1977; 18: 93–100.
10.
AcostaJ.H.: Hypertension in chronic renal disease.Kidney Int.1982; 23: 702–712.
11.
FademS.Z., LifschitzM.D.: Use of saralasin in end-stage renal disease.Kidney Int.1979; 15: S93–S100.